公开(公告)号：US12016842B2

公开(公告)日：2024-06-25

申请号：US17230861

申请日：2021-04-14

Applicant: Genentech, Inc.

Inventor： Andrew Polson ,  Shang-Fan Yu ,  Yu-Waye Chu ,  Michael Wenger ,  Jamie Harue Hirata ,  Dan Lu

IPC: A61K39/00 ,  A61K31/4184 ,  A61K31/454 ,  A61K31/553 ,  A61K31/635 ,  A61K39/395 ,  A61K45/06 ,  A61K47/68 ,  C07K16/28 ,  C07K16/30

CPC classification number: A61K31/4184 ,  A61K31/454 ,  A61K31/553 ,  A61K31/635 ,  A61K39/3955 ,  A61K39/39558 ,  A61K45/06 ,  A61K47/6803 ,  A61K47/6849 ,  A61K47/6867 ,  A61K47/6889 ,  C07K16/2803 ,  C07K16/2887 ,  C07K16/3061 ,  A61K2039/507 ,  A61K2039/54 ,  A61K2039/545 ,  A61K2300/00 ,  C07K2317/24 ,  A61K39/39558 ,  A61K2300/00 ,  A61K31/4184 ,  A61K2300/00 ,  A61K31/635 ,  A61K2300/00 ,  A61K31/454 ,  A61K2300/00 ,  A61K31/553 ,  A61K2300/00 ,  A61K39/3955 ,  A61K2300/00

Abstract: Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.

公开(公告)号：US11000510B2

公开(公告)日：2021-05-11

申请号：US16358410

申请日：2019-03-19

Applicant: Genentech, Inc.

Inventor： Andrew Polson ,  Shang-Fan Yu ,  Yu-Waye Chu ,  Michael Wenger ,  Jamie Harue Hirata ,  Dan Lu

IPC: A61K39/00 ,  A61K31/4184 ,  A61K39/395 ,  A61K47/68 ,  A61K45/06 ,  C07K16/28 ,  C07K16/30 ,  A61K31/553 ,  A61K31/454 ,  A61K31/635

Abstract: Provided herein are methods of treating B-cell proliferative disorders in particular Follicular Lymphoma and/or Diffuse Large B-Cell Lymphoma using immunoconjugates comprising anti-CD79b antibodies in combination with additional therapeutic agents.